Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: Herceptin

xB3-001 is the lead program at Bioasis and is an xB3 peptide vector-trastuzumab fusion. Trastuzumab is sold under the brand name Herceptin. There's a good summary of the lead program and pre-clinical data in the recent corporate update presentation.

 

 

Share
New Message
Please login to post a reply